There are around 5,000 new cases of type 2 diabetes each year in young people in the United States. Type 2 is a growing problem among young people. Last week, the FDA approved the drug Victoza for use in young people ages 10 to 17. Victoza was approved for use in adults in 2010. The approval for youth came after a trial done on 134 patients 10 years and older.
The pediatric trial led by Yale University showed that liraglutide can help control blood glucose levels. The study was published in the New England Journal of Medicine. In the study, Victoza was proven to be successful and safe with minimal side effects.
What is Victoza?
Victoza (liraglutide) is an injectable medication that can help manage blood sugar levels in those with type 2. This is the first non-insulin drug that has been approved for use in youth with diabetes. Victoza will only be needed for children in certain cases where blood sugar can’t be controlled.
Ross Wollen of the diabetes website A Sweet Life called this FDA approval “bittersweet,” since it means looking away from more natural and proven means of managing diabetes like changing diet and being more active.
What are the side effects of Victoza?
Some common side effects are:
- Low blood sugar
- Abdominal pain
- Pain at the injection site
Novo Nordisk, the company who created Victoza, may have more drugs for diabetes in the works. If medications are needed for type 2, they should be used in conjunction with diet changes and exercise.